AstraZeneca divestment of Movantik to RedHill Biopharma completed Medical Dialogues Bureau4 April 2020 11:00 AM ISTUK: AstraZeneca has completed the previously communicated agreement to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada,...
RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection Medical Dialogues Bureau11 Nov 2019 9:15 AM ISTThe drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for...